Atlas Trials

Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's Disease

Clinical trial NCT02065570 · COMPLETED

Trial details

NCT number
NCT02065570
Sponsor
AbbVie
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2014-05-01
Primary completion
2020-01-30
Enrollment
514

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.